Vasovagal/pre faint symptoms in voluntary whole blood and apheresis plasma donors Signs and Symptoms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Eligible to donate as per the Australian Red Cross Lifeblood Guidelines for the Selection of Blood Donors 2. Donating whole blood or plasma for the first time 3. Willing and able to provide informed consent 4. Has a plasma or whole blood appointment at one of the participating donor centres (appointment made as a walk-in donor or scheduled appointment)
Exclusion criteria
Exclusion criteria: 1. Unwilling or unable to provide informed consent 2. Lack of understanding of the English language necessary to complete questionnaires. This study will not use translation services or interpreters 3. Contacted for a research study in the last 6 months as per Lifeblood contact policy 4. Donors with therapeutic, autologous, sample or platelet donation appointments 5. Lifeblood employees
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Self-reported vasovagal symptoms measured using the Blood Donation Reactions Inventory (BDRI) at the haemoglobin test, needle insertion, first red cell return (plasma only), saline administration (plasma only), needle removal, and post-donation 2. Donation fear measured using a single fear question pre- and post-donation 3. Venipuncture pain measured using a self-report post-donation 4. Donor anxiety measured using the Blood Donor Anxiety Scale post-donation 5. Donor satisfaction with biometric sensor device measured using a self-report post-donation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Staff-recorded vasovagal reactions measured using Australian Red Cross Lifeblood standard procedures at any point at the donation centre 2. Donor return measured using Australian Red Cross Lifeblood records at 6-month follow-up 3. Time taken to return measured using the donor’s next attendance date as recorded by Australian Red Cross Lifeblood at 6-month follow up | — |
Countries
Australia